Paid tool

ibex-ai.com

AI-powered digital pathology platform providing trusted, highly accurate cancer diagnostic solutions.

Visitibex-ai.com
Intro

What is ibex-ai.com?

Ibex Medical Analytics is a global leader in AI-powered cancer diagnostics, providing highly advanced digital pathology solutions. Through its core AI platform, Ibex helps pathologists improve diagnostic accuracy and clinical workflows for several major cancer types. The platform includes dedicated modules like Ibex Prostate, Ibex Breast, and Ibex Gastric to analyze complex tissue samples. It aids in tasks like HER2 IHC interpretation, determining Gleason grading, detecting perineural invasion, and conducting nuclear grading. Ibex AI functions essentially as a 'second read' or AI consultant, reducing pathology workloads while ensuring small or high-grade cancer foci are not missed, placing it at the forefront among companies giving solutions for semi automatic breast cancer identification.

ibex-ai.com at a glance
Contact for Pricing14K monthly visitsPaid access
Pricing

ibex-ai.com Pricing Plans

Compare ibex-ai.com free options, ibex-ai.com paid pricing plans, and usage notes before you choose the best way to use this AI tool in 2026.

Contact for Pricing

Pricing updated:Jun 12, 2026

Features

ibex-ai.com AI Features

AI-powered tissue analysis across multiple tissue types including prostate, breast, and gastricHigh-accuracy cancer detection trained on deep learning datasets of over 10 million slidesClinical feature identification including Gleason grading, tumor sizing, and nuclear gradingAdvanced biomarkers support including automated HER2 IHC interpretationProspective quality control acting as a reliable digital second read for pathology teams
Pros & Cons

ibex-ai.com Pros and Cons

Pros

  • Clinically proven accuracy with an area under the curve close to near perfect
  • Reduces pathology workloads and optimizes turnaround times across the cancer pathway
  • Acts as a built-in quality control to catch small or easily missed high-grade cancer foci
  • Backed by $55 million in Series C funding to drive global adoption and rollout

Limitations

  • Requires adoption of digital pathology infrastructure (digital slides instead of traditional microscopes)
  • Pricing plans and implementation costs are not publicly listed

ibex-ai.com FAQ

The platform offers specialized diagnostic tools for several tissue types, including Ibex Prostate, Ibex Breast, Ibex Breast HER2, and Ibex Gastric.